• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bioventus Inc. - Class A Common Stock (NQ:BVS)

    8.750 +0.030 (+0.34%)
    Streaming Delayed Price Updated: 10:48 AM EST, Feb 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Bioventus Inc. - Class A Common Stock

    < Previous 1 2 3 4 Next >
    News headline image
    Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Reports Third Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
    From Halper Sadeh LLC
    Via Business Wire
    News headline image
    Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Reports Second Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Reports First Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Reports Third Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Reports Second Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Reports First Quarter Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
    From Bioventus, Inc.
    Via GlobeNewswire
    News headline image
    BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.